Bilirubin participates in protecting of heme oxygenase-1 induction by quercetin against ethanol hepatotoxicity in cultured rat hepatocytes

Alcohol

Volumn 47, Issue 2, 2013, Pages 141-148

  Jie, Qinfeng ^a,b   Tang, Yuhan ^a   Deng, Yue ^a   Li, Yanyan ^a   Shi, Yanru ^a   Gao, Chao ^a   Xing, Mingyou ^a   Wang, Di ^a   Liu, Liegang ^a   Yao, Ping ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Jiangxi Center for Disease Control and Prevention   (China)

Author keywords

Bilirubin; Ethanol; Heme oxygeanse 1; Oxidative damage

Indexed keywords

ALCOHOL; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GLUTATHIONE; HEME OXYGENASE 1; HEMIN; INTERLEUKIN 6; LACTATE DEHYDROGENASE; MALONALDEHYDE; PROTOPORPHYRIN; QUERCETIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; LIVER CELL; LIVER PROTECTION; LIVER TOXICITY; MALE; NONHUMAN; OXIDATIVE STRESS; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; BILIRUBIN; CELLS, CULTURED; ENZYME INDUCTION; ETHANOL; GLUTATHIONE; HEME OXYGENASE-1; HEPATOCYTES; INTERLEUKIN-6; MALE; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; QUERCETIN; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 84874019681     PISSN: 07418329     EISSN: 18736823     Source Type: Journal    
DOI: 10.1016/j.alcohol.2012.10.006     Document Type: Article

References (61)

1. Albano E. Oxidative mechanisms in the pathogenesis of alcoholic liver disease. Molecular Aspects of Medicine 2008, 29:9-16.
2. Anjaneyulu M., Chopra K. Quercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats. Clinical and Experimental Pharmacology and Physiology 2004, 31:244-248.
3. Bailey S.M., Cunningham C.C. Contribution of mitochondria to oxidative stress associated with alcoholic liver disease. Free Radical Biology and Medicine 2002, 32:11-16.
4. Bao W., Li K., Rong S., Yao P., Hao L.P., Ying C.J., et al. Curcumin alleviates ethanol-induced hepatocytes oxidative damage involving heme oxygenase-1 induction. Journal of Ethnopharmacology 2010, 128(2):549-553.
5. Baranano D.E., Rao M., Ferris C.D., Snyder S.H. Biliverdin reductase: a major physiologic cytoprotectant. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:16093-16098.
6. Basiglio C.L., Arriaga S.M., Pelusa F., Almara A.M., Kapitulnik J., Mottino A.D. Complement activation and disease: protective effects of hyperbilirubinaemia. Clinical Science (London) 2010, 118:99-113.
7. Belanger S., Lavoie J.C., Chessex P. Influence of bilirubin on the antioxidant capacity of plasma in newborn infants. Biology of the Neonate 1997, 71:233-238.
8. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 1976, 72:248-254.
9. Cheriyath P., Gorrepati V.S., Peters I., Nookala V., Murphy M.E., Srouji N., et al. High total bilirubin as a protective factor for diabetes mellitus: an analysis of NHANES data from 1999-2006. Journal of Clinical Medicine Research 2010, 2:201-206.
10. Clark J.E., Foresti R., Sarathchandra P., Kaur H., Green C.J., Motterlini R. Heme oxygenase-1-derived bilirubin ameliorated postischemic myocardial dysfunction. American Journal of Physiology Heart and Circulatory Physiology 2000, 278(2):643-651.
11. Colletti L.M., Cortis A., Lukacs N., Kunkel S.L., Green M., Strieter R.M. Tumor necrosis factor up-regulates intercellular adhesion molecule 1, which is important in the neutrophil-dependent lung and liver injury associated with hepatic ischemia and reperfusion in the rat. Shock 1998, 10:182-191.
12. Dekker D., Dorresteijn M.J., Pijnenburg M., Heemskerk S., Rasing-Hoogveld A., Burger D.M., et al. The bilirubin-increasing drug atazanavir improves endothelial function in patients with type 2 diabetes mellitus. Arteriosclerosis, Thrombosis, and Vascular Biology 2011, 31:458-463.
13. DiCecco S.R., Francisco-Ziller N. Nutrition in alcoholic liver disease. Nutrition in Clinical Practice 2006, 21:245-254.
14. Eady J.J., Orta T., Dennis M.F., Stratford M.R., Peacock J.H. Glutathione determination by the Tietze enzymatic recycling assay and its relationship to cellular radiation response. British Journal of Cancer 1995, 72:1089-1095.
15. Farombi E.O., Surh Y.J. Heme oxygenase-1 as a potential therapeutic target for hepatoprotection. Journal of Biochemistry and Molecular Biology 2006, 39:479-491.
16. Foresti R., Green C.J., Motterlini R. Generation of bile pigments by haem oxygenase: a refined cellular strategy in response to stressful insults. Biochemical Society Symposia 2004, 177-192.
17. Frei B., Stocker R., Ames B.N. Antioxidant defenses and lipid peroxidation in human blood plasma. Proceedings of the National Academy of Sciences of the United States of America 1988, 85:9748-9752.
18. Fuhua P., Xuhui D., Zhiyang Z., Ying J., Yu Y., Feng T., et al. Antioxidant status of bilirubin and uric acid in patients with myasthenia gravis. Neuroimmunomodulation 2012, 19:43-49.
19. Fujiwara R., Nguyen N., Chen S., Tukey R.H. Developmental hyperbilirubinemia and CNS toxicity in mice humanized with the UDP glucuronosyltransferase 1 (UGT1) locus. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:5024-5029.
20. Gao B., Balatter R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 2011, 141(5):1572-1585.
21. Gomes A.S., Gadelha G.G., Lima S.J., Garcia J.A., Medeiros J.V., Havt A., et al. Gastroprotective effect of heme-oxygenase 1/biliverdin/CO pathway in ethanol-induced gastric damage in mice. European Journal of Pharmacology 2010, 642:140-145.
22. Gonzalez-Quintela A., Campos J., Loidi L., Quinteiro C., Perez L.F., Gude F. Serum TNF-alpha levels in relation to alcohol consumption and common TNF gene polymorphisms. Alcohol 2008, 42:513-518.
23. Gozzelino R., Jeney V., Soares M.P. Mechanisms of cell protection by heme oxygenase-1. Annual Review of Pharmacology and Toxicology 2010, 50:323-354.
24. Greabu M., Olinescu R., Kummerow F.A., Crocnan D.O. The levels of bilirubin may be related to an inflammatory condition in patients with coronary heart disease. Acta Poloniae Pharmaceutica 2001, 58:225-231.
25. Grochot-Przeczek A., Dulak J., Jozkowicz A. Haem oxygenase-1: non-canonical roles in physiology and pathology. Clinical Science (London) 2012, 122:93-103.
26. Hayashi S., Takamiya R., Yamaguchi T., Matsumoto K., Tojo S.J., Tamatani T., et al. Induction of heme oxygenase-1 suppresees venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme. Circulation Research 1999, 85(8):663-671.
27. Hoek J.B., Pastorino J.G. Ethanol, oxidative stress, and cytokine-induced liver cell injury. Alcohol 2002, 27:63-68.
28. Jozkowicz A., Was H., Dulak J. Heme oxygenase-1 in tumors: is it a false friend?. Antioxidants & Redox Signaling 2007, 9(12):2099-2117.
29. Kadl A., Pontiller J., Exner M., Leitinger N. Single bolus injection of bilirubin improves the clinical outcome in a mouse model of endotoxemia. Shock 2007, 28:582-588.
30. Kawamura K., Ishikawa K., Wada Y., Kimura S., Matsumoto H., Kohro T., et al. Bilirubin from heme oxygenase-1 attenuates vascular endothelial activation and dysfunction. Arteriosclerosis Thrombosis and Vascular Biology 2005, 25(1):155-160.
31. Keshavan P., Deem T.L., Schwemberger S.J., Babcock G.F., Cook-Mills J.M., Zucker S.D. Unconjugated bilirubin inhibits VCAM-1-mediated transendothelial leukocyte migration. The Journal of Immunology 2005, 174:3709-3718.
32. Kim S.J., Park J.G., Lee S.M. Protective effect of heme oxygenase-1 induction against hepatic injury in alcoholic steatotic liver exposed to cold ischemia/reperfusion. Life Sciences 2012, 90:169-176.
33. Ku B.M., Joo Y., Mun J., Roh G.S., Kang S.S., Cho G.J., et al. Heme oxygenase protects hippocampal neurons from ethanol-induced neurotoxicity. Neuroscience Letters 2006, 405:168-171.
34. Lv X., Chen Z., Li J., Zhang L., Liu H., Huang C., et al. Caffeine protects against alcoholic liver injury by attenuating inflammatory response and oxidative stress. Inflammation Research 2010, 59:635-645.
35. Maghzal G.J., Leck M.C., Collonson E., Li C., Stocker R. Limited role for bilirubin-biliverdin redox amplification cycle in the cellular antioxidant protection by biliverdin reductase. J Biol Chem 2009, 284(43):29251-29259.
36. Maines M.D. New insights into biliverdin reductase functions: linking heme metabolism to cell signaling. Physiology 2005, 20:382-389.
37. Mancuso C., Pani G., Calabrese V. Bilirubin: an endogenous scavenger of nitric oxide and reactive nitrogen species. Redox Report 2006, 11:207-213.
38. Mazzone G.L., Rigato I., Ostrow J.D., Bossi F., Bortoluzzi A., Sukowati C.H., et al. Bilirubin inhibits the TNFalpha-related induction of three endothelial adhesion molecules. Biochemical and Biophysical Research Communications 2009, 386:338-344.
39. Neuzil J., Stocker R. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. The Journal of Biological Chemistry 1994, 269:16712-16719.
40. Nussler A.K., Hao L., Knobeloch D., Yao P., Nussler N.C., Wang Z., et al. Protective role of HO-1 for alcohol-dependent liver damage. Journal of Digestive Diseases 2010, 28:792-798.
41. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 1979, 95:351-358.
42. Ohnaka K., Kono S., Inoguchi T., Yin G., Morita M., Adachi M., et al. Inverse associations of serum bilirubin with high sensitivity C-reactive protein, glycated hemoglobin, and prevalence of type 2 diabetes in middle-aged and elderly Japanese men and women. Diabetes Research and Clinical Practice 2010, 88:103-110.
43. Oveson B.C., Iwase T., Hackett S.F., Lee S.Y., Usui S., Sedlak T.W., et al. Constituents of bile, bilirubin and TUDCA, protect against oxidative stress-induced retinal degeneration. Journal of Neurochemistry 2011, 116:144-153.
44. Peng F., Yang Y., Liu J., Jiang Y., Zhu C., Deng X., et al. Low antioxidant status of serum uric acid, bilirubin and albumin in patients with neuromyelitis optica. European Journal of Neurology 2012, 19:277-283.
45. Romeo J., Warnberg J., Nova E., Diaz L.E., Gomez-Martinez S., Marcos A. Moderate alcohol consumption and the immune system: a review. British Journal of Nutrition 2007, 98(Suppl. 1):S111-S115.
46. Roseth S., Hansen T.W., Fonnum F., Walaas S.I. Bilirubin inhibits transport of neurotransmitters in synaptic vesicles. Pediatric Research 1998, 44:312-316.
47. Schipper H.M., Gupta A., Szarek W.A. Suppression of gial HO-1 activity as a potential neurotherapeutic intervention in AD. Current Alzheimer Research 2009, 6(5):424-430.
48. Seglen P.O. Hepatocyte suspensions and cultures as tools in experimental carcinogenesis. Journal of Toxicology and Environmental Health 1979, 5:551-560.
49. Takahashi T., Shimizu H., Morimatsu H., Inoue K., Akagi R., Morita K., et al. Heme oxygenase-1: a fundamental guardian against oxidative tissue injuries in acute inflammation. Mini Reviews in Medicinal Chemisrty 2007, 7:745-753.
50. Tanaka M., Fukui M., Tomiyasu K., Akabame S., Nakano K., Hasegawa G., et al. Low serum bilirubin concentration is associated with coronary artery calcification (CAC). Atherosclerosis 2009, 206:287-291.
51. Tang L.M., Wang Y.P., Wang K., Pu L.Y., Zhang F., Li X.C., et al. Exogenous biliverdin ameliorates ischemia-reperfusion injury in small-for-size rat liver grafts. Transplantation Proceedings 2007, 39:1338-1344.
52. Tell G., Gustincich S. Redox state, oxidative stress, and molecular mechanisms of protective and toxic effects of bilirubin on cells. Current Pharmaceutical Design 2009, 15:2908-2914.
53. Vera T., Stec D.E. Moderate hyperbilirubinemia improves renal hemodynamics in ANG II-dependent hypertension. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2010, 299:R1044-R1049.
54. Vitek L., Ostrow J.D. Bilirubin chemistry and metabolism; harmful and protective aspects. Current Pharmaceutical Design 2009, 15:2869-2883.
55. Wang W.W., Smith D.L., Zucker S.D. Bilirubin inhibits iNOS expression and NO production in response to endotoxin in rats. Hepatology 2004, 40:424-433.
56. Wu D., Cederbaum A.I. Oxidative stress and alcoholic liver disease. Seminars in Liver Disease 2009, 29:141-154.
57. Wu T.W., Fung K.P., Yang C.C. Unconjugated bilirubin inhibits the oxidation of human low density lipoprotein better than Trolox. Life Sciences 1994, 54:P477-P481.
58. Yao P., Hao L., Nussler N., Lehmann A., Song F., Zhao J., et al. The protective role of HO-1 and its generated products (CO, bilirubin, and Fe) in ethanol-induced human hepatocyte damage. American Journal of Physiology - Gastrointestinal and Liver Physiology 2009, 296:G1318-G1323.
59. Yao P., Nussler A., Liu L., Hao L., Song F., Schirmeier A., et al. Quercetin protects human hepatocytes from ethanol-derived oxidative stress by inducing heme oxygenase-1 via the MAPK/Nrf2 pathways. Journal of Hepatology 2007, 47:253-261.
60. Yoshino S., Hamasaki S., Ishida S., Kataoka T., Yoshikawa A., Oketani N., et al. Relationship between bilirubin concentration, coronary endothelial function, and inflammatory stress in overweight patients. Journal of Atherosclerosis and Thrombosis 2011, 18:403-412.
61. Zhu H., Wang J., Jiang H., Ma Y., Pan S., Reddy S., et al. Bilirubin protects grafts against nonspecific inflammation-induced injury in syngeneic intraportal islet transplantation. Experimental and Molecular Medicine 2010, 42:739-748.